Knight, Jason S.

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine

Neutrophil, Myeloperoxidase and Oxidative MechanismsCOVID-19 Clinical Research Studies

Cited by 1,486

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M.-C., Amoura, Z., Andrade, D., Andreoli, L., Artim-Esen, B., et al. (2023) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 493

Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice

Knight, J. S., Subramanian, V., O'Dell, A. A., Yalavarthi, S., Zhao, W., Smith, C. K., Hodgin, J. B., Thompson, P. R., & Kaplan, M. J. (2015) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 443

Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus

Smith, C. K., Vivekanandan‐Giri, A., Tang, C., Knight, J. S., Mathew, A., Padilla, R. L., Gillespie, B. W., Carmona‐Rivera, C., Liu, X., Subramanian, V., et al. (2014) · Arthritis & Rheumatology

Neutrophil, Myeloperoxidase and Oxidative MechanismsSystemic Lupus Erythematosus Research

Cited by 216

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Sevim, E., Zisa, D., Andrade, D., Sciascia, S., Pengo, V., Tektonidou, M. G., Ugarte, A., Gerosa, M., Belmont, H. M., Zamorano, M. A. A., et al. (2022) · Arthritis Care & Research

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 88

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Erkan, D., Unlu, O., Sciascia, S., Belmont, H. M., Branch, D. W., Cuadrado, M. J., Gonzalez, E., Knight, J. S., Uthman, I., Willis, R., et al. (2018) · Lupus

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 66

Antiphospholipid antibody profile stability over time: prospective results from the APS ACTION clinical database and repository

Gkrouzman, E., Sevim, E., Finik, J., Andrade, D., Pengo, V., Sciascia, S., Tektonidou, M. G., Ugarte, A., Chighizola, C. B., Belmont, H. M., et al. (2021) · The Journal of Rheumatology

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 24

Antiphospholipid syndrome: an update for clinicians and scientists

Vreede, A. P., Bockenstedt, P. L., & Knight, J. S. (2017) · Current Opinion in Rheumatology

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 22